| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Moon Young Kim | |
| Seung Up Kim | |||
| Hong Soo Kim | |||
| Jae Young Jang | |||
| Sae Hwan Lee | |||
| Sang Gyune Kim | |||
| Soung Won Jeong | |||
| Hyun Young Woo | |||
| Jeong Heo | |||
| Ki Tae Suk | |||
| Soo Young Park | |||
| Soon Koo Baik | |||
| Tae Yeob Kim | |||
| Won Young Tak | |||
| P2860 | cites work | Contrast-enhanced ultrasound (CEUS) for the characterization of focal liver lesions in clinical practice (DEGUM Multicenter Trial): CEUS vs. MRI--a prospective comparison in 269 patients | Q84587967 |
| Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma and liver metastases | Q95802516 | ||
| Computed Tomography — An Increasing Source of Radiation Exposure | Q22121933 | ||
| Advanced Hepatocellular Carcinoma: Early Evaluation of Response to Bevacizumab Therapy at Dynamic Contrast-enhanced US with Quantification—Preliminary Results 1 | Q22255600 | ||
| Management of hepatocellular carcinoma: An update | Q27860530 | ||
| Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms | Q28139442 | ||
| Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS | Q28278903 | ||
| Management of hepatocellular carcinoma | Q29616230 | ||
| Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma | Q30479629 | ||
| Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter-study in comparison to CT and MRI. | Q30487452 | ||
| Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A. | Q30542673 | ||
| CT and MR imaging of hepatic metastases | Q33853795 | ||
| Echocardiography of the aortic root | Q34054071 | ||
| Liver mass evaluation with ultrasound: the impact of microbubble contrast agents and pulse inversion imaging | Q34298610 | ||
| Hepatic adenomas: imaging and pathologic findings | Q34307927 | ||
| Risk of cancer from diagnostic X-rays: estimates for the UK and 14 other countries | Q34311769 | ||
| Natural history of hepatic haemangiomas: clinical and ultrasound study | Q34393786 | ||
| The role of contrast-enhanced ultrasound in the detection of focal liver leasions. | Q34495408 | ||
| Tissue harmonic and contrast-specific imaging: back to gray scale in ultrasound | Q34545473 | ||
| Ultrasonographic detection of focal liver lesions: increased sensitivity and specificity with microbubble contrast agents | Q35114542 | ||
| Characterization of focal liver lesions with contrast-enhanced ultrasound | Q35688715 | ||
| Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. | Q35852165 | ||
| Focal liver lesions: evaluation with contrast-enhanced ultrasonography | Q35881328 | ||
| Focal nodular hyperplasia | Q36369048 | ||
| An algorithm for the diagnosis of focal liver masses using microbubble contrast-enhanced pulse-inversion sonography | Q36457263 | ||
| Microbubble contrast for radiological imaging: 1. Principles. | Q36461441 | ||
| Benign liver masses: imaging with microbubble contrast agents. | Q36461455 | ||
| Focal liver masses: enhancement patterns on contrast-enhanced images--concordance of US scans with CT scans and MR images | Q36647571 | ||
| New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice. | Q36701684 | ||
| Focal liver lesions: role of contrast-enhanced ultrasound | Q36953899 | ||
| Are metastases really hypovascular in the arterial phase? The perspective based on contrast-enhanced ultrasonography | Q36980220 | ||
| Focal liver lesions: contrast-enhanced ultrasound | Q37101338 | ||
| Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions | Q37587562 | ||
| Imaging of focal liver lesions. | Q37588846 | ||
| Contrast-enhanced ultrasound techniques for guiding and assessing response to locoregional treatments for hepatocellular carcinoma | Q37771184 | ||
| Microbubble-enhanced US in body imaging: what role? | Q37790181 | ||
| Contrast-enhanced ultrasound in abdominal imaging | Q37924165 | ||
| Saccharide-based contrast agents. Characteristics and diagnostic potential. | Q40765364 | ||
| Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout | Q43121730 | ||
| Real-time contrast-enhanced ultrasonography of resected and immunohistochemically proven hepatic angiomyolipomas | Q43216289 | ||
| Early response to anti-tumoral treatment in hepatocellular carcinoma--can quantitative contrast-enhanced ultrasound predict outcome? | Q43877743 | ||
| Efficacy of perflubutane microbubble-enhanced ultrasound in the characterization and detection of focal liver lesions: phase 3 multicenter clinical trial. | Q45960644 | ||
| Small nodules (1-2 cm) in liver cirrhosis: characterization with contrast-enhanced ultrasound | Q46332508 | ||
| Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. | Q46704438 | ||
| Practice guidelines for management of hepatocellular carcinoma 2009 | Q50247644 | ||
| Angioarchitecture and blood circulation in focal nodular hyperplasia of the liver. | Q50522368 | ||
| Solitary necrotic nodule of the liver: contrast-enhanced sonography. | Q51045377 | ||
| Contrast-enhanced ultrasonographic spoke-wheel sign in hepatic focal nodular hyperplasia. | Q51143843 | ||
| Is microbubble-enhanced ultrasonography sufficient for assessment of response to percutaneous treatment in patients with early hepatocellular carcinoma? | Q51198337 | ||
| Management of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. | Q51541140 | ||
| Spontaneous hepatic rupture: 13-year experience of a single center. | Q51559378 | ||
| Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS). | Q51619398 | ||
| Contrast-enhanced ultrasound for the characterization of focal liver lesions--diagnostic accuracy in clinical practice (DEGUM multicenter trial). | Q51654537 | ||
| Early assessment of the therapeutic response to radio frequency ablation for hepatocellular carcinoma: utility of gray scale harmonic ultrasonography with a microbubble contrast agent. | Q51797165 | ||
| Computer-assisted diagnosis of focal liver lesions on CT images evaluation of the Perceptron algorithm. | Q51966064 | ||
| Diagnosis of benign and malignant portal vein thrombosis in cirrhotic patients with hepatocellular carcinoma: color Doppler US, contrast-enhanced US, and fine-needle biopsy. | Q52572377 | ||
| Assessment of a biliary hamartoma with contrast-enhanced sonography using two different contrast agents. | Q52916364 | ||
| Characterization of focal liver lesions with contrast-enhanced ultrasound. | Q53302436 | ||
| Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlation with cellular differentiation. | Q53370206 | ||
| Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. | Q53407917 | ||
| Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. | Q53451958 | ||
| Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. | Q53476429 | ||
| Contrast-enhanced ultrasound of histologically proven liver hemangiomas. | Q53484750 | ||
| Correlation between enhancement pattern of hepatocellular carcinoma on real-time contrast-enhanced ultrasound and tumour cellular differentiation on histopathology. | Q53518865 | ||
| Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. | Q53576054 | ||
| Low mechanical index contrast-enhanced sonographic findings of pyogenic hepatic abscesses. | Q53633546 | ||
| Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. | Q53649670 | ||
| Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation | Q56785949 | ||
| Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography—A prospective study | Q56836373 | ||
| Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver | Q56988541 | ||
| The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations | Q56997483 | ||
| Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound | Q58021493 | ||
| Clinical, Morphologic, and Molecular Features Defining So-Called Telangiectatic Focal Nodular Hyperplasias of the Liver | Q58408401 | ||
| Contrast-enhanced ultrasonography and spiral computed tomography in the detection and characterization of portal vein thrombosis complicating hepatocellular carcinoma | Q61650947 | ||
| On the oscillation mode of gas-filled micropores | Q70074396 | ||
| Pulse inversion imaging of liver blood flow: improved method for characterizing focal masses with microbubble contrast | Q73364100 | ||
| Contrast-enhanced, wide-band harmonic gray scale imaging of hepatocellular carcinoma: correlation with helical computed tomographic findings | Q73519491 | ||
| Color and power Doppler sonography of liver hemangiomas: a dream unfulfilled? | Q73635345 | ||
| Liver hemangioma: US-guided 18-gauge core-needle biopsy | Q73656268 | ||
| Dynamic sonography of hepatic tumors | Q74537104 | ||
| Etiological analysis of focal nodular hyperplasia of the liver, with emphasis on similar abnormal vasculatures to nodular regenerative hyperplasia and idiopathic portal hypertension | Q77202920 | ||
| [Evaluation of Doppler sonographic criteria for the differentiation of hepatocellular carcinomas and regenerative nodules in patients with liver cirrhosis] | Q77966242 | ||
| Late-phase pulse-inversion sonography using the contrast agent levovist: differentiation between benign and malignant focal lesions of the liver | Q78397096 | ||
| Guidance and control of percutaneous treatments with contrast-enhanced ultrasound | Q79767197 | ||
| Dynamic US contrast study of the liver: Vascular and delayed parenchymal phase | Q79774821 | ||
| Treatment of hepatocellular carcinoma with percutaneous radiofrequency ablation: usefulness of contrast harmonic sonography for lesions poorly defined with B-mode sonography | Q80223124 | ||
| Guidelines for the use of contrast agents in ultrasound. January 2004 | Q80428190 | ||
| Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008 | Q80689480 | ||
| Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions | Q81631952 | ||
| Frequency of tumor entities among liver tumors of unclear etiology initially detected by sonography in the noncirrhotic or cirrhotic livers of 1349 patients. Results of the DEGUM multicenter study | Q82912935 | ||
| Primum non nocere? Why can't we use second generation ultrasound contrast agents for the examination of children? | Q83390649 | ||
| Value of contrast-enhanced sonography in the diagnosis of peripheral intrahepatic cholangiocarcinoma | Q84231033 | ||
| Focal liver processes: "better is the enemy of good": CEUS in the fast lane | Q84422990 | ||
| Contrast enhanced ultrasound for the diagnosis of hepatocellular carcinoma (HCC): comments on AASLD guidelines | Q84472953 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | liver disease | Q929737 |
| contrast agent | Q6849688 | ||
| liver neoplasm | Q18558073 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 1-16 | |
| P577 | publication date | 2013-03-01 | |
| 2013-03-25 | |||
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions | |
| P478 | volume | 19 |
| Q91576684 | A novel method to determine hepatic segments using Sonazoid, an ultrasound contrast agent |
| Q30365612 | Added Value of Contrast-Enhanced Ultrasound on Biopsies of Focal Hepatic Lesions Invisible on Fusion Imaging Guidance. |
| Q26860623 | Alcohol and hepatocellular carcinoma: a review and a point of view |
| Q35861410 | CONSUMER PREFERENCES FOR SCANNING MODALITY TO DIAGNOSE FOCAL LIVER LESIONS. |
| Q37587292 | Characterization of primary hepatic carcinosarcoma by contrast-enhanced ultrasonography: a case report |
| Q30438199 | Clinically useful diagnostic tool of contrast enhanced ultrasonography for focal liver masses: comparison to computed tomography and magnetic resonance imaging |
| Q40784838 | Continuous dynamic registration of microvascularization of liver tumors with contrast-enhanced ultrasound |
| Q88578665 | Contrast-Enhanced Ultrasonography in Sclerotherapy for Ovarian Endometrial Cyst |
| Q30408973 | Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline |
| Q45418636 | Contrast-enhanced ultrasound for focal liver lesions. Is it necessary an hepatologist expert in ultrasound techniques in the third millennium? |
| Q38931032 | Diagnostic Accuracy of Hepatic Vein Arrival Time Performed with Contrast-Enhanced Ultrasonography for Cirrhosis: A Systematic Review and Meta-Analysis |
| Q90607927 | Differentiation of atypical hepatic hemangioma from liver metastases: Diagnostic performance of a novel type of color contrast enhanced ultrasound |
| Q64071505 | Dynamic Contrast-Enhanced Ultrasound of Gastric Cancer: Correlation with Perfusion CT and Histopathology |
| Q41971800 | Efficacy of contrast grey scale ultrasound in characterization of hepatic focal lesions |
| Q51695130 | Evaluation of the diagnostic accuracy of CEUS in children with benign and malignant liver lesions and portal vein anomalies. |
| Q46680489 | Focal Liver Lesions: Computer-aided Diagnosis by Using Contrast-enhanced US Cine Recordings. |
| Q26781493 | Hepatic hemangioma -review-. |
| Q53329472 | Inertial cavitation threshold of nested microbubbles. |
| Q39157128 | Influence of nesting shell size on brightness longevity and resistance to ultrasound-induced dissolution during enhanced B-mode contrast imaging |
| Q37017386 | Optimal injection rate of ultrasound contrast agent for evaluation of focal liver lesions using an automatic power injector: a pilot study |
| Q30407182 | Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma |
| Q30439812 | Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US. |
| Q98894930 | The AFSUMB Consensus Statements and Recommendations for the Clinical Practice of Contrast-Enhanced Ultrasound using Sonazoid |
| Q30407178 | The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study |
Search more.